Business Wire

DEENOVA

20.12.2022 06:01:43 CET | Business Wire | Press release

Share
Deenova Celebrates a Year of Undisputed Growth With the Latest Award of Piacenza AUSL Public Tender

After successful market entries in Germany, UK and the 3 years of record breaking sales in France, Deenova consolidates its leadership position in Italy with the award of the Piacenza AUSL Public Tender, confirming Deenova’s 100% customer retention rate since 2007 and an undisputed technological leadership in the field of hospital pharmacy automation aimed at improving processes, patient safety and personnel time efficiency, for healthcare institutions.

The public tender named 'telematic restricted procedure for the entrusting of logistics support services and needed medical devices’ includes the Deenova flagship solutions such as Orbit software, D1 All-In-1 Stations, D1 All-In-1 Trolley, but also the All-in-1 cabinets for the handling of not unit dose medications (All-In-1 Meds, All-In-1 Fridge and All-In-1 Narcotics) and D8 RFID technology for medical devices.

"The 6 years tender at Piacenza AUSLGiorgio Pavesi, CEO of Deenova, stated - confirms the complete satisfaction with our automation solutions among the existing customer base. We provide the highest level of safety and efficiency for traceability of medications and medical devices through restless technological development: in Piacenza hospitals we’ll add new solutions to those already used such as Kanban methodology for automatic reordering of low-cost devices and Real Time Location System for traceability of the patient’s path in surgery unit”.

The Piacenza AUSL has around 750 beds in the 4 hospitals of Bobbio, Castel San Giovanni, Fiorenzuola and Piacenza, with 91 operating units, including the Mental Health Centres and the Hospital Pharmacy. During the last X SIFACT Congress "Clinical outcomes: a shared commitment and responsibility" Piacenza AUSL has been awarded as best abstract for the poster "Management of batch in single-dose therapy prepared by Hospital Pharmacy Service for Mental Health Centres". The project introduced Deenova error-free solutions to ensure the complete traceability of unit-dose therapies, favouring therapeutic adherence and clinical risk management. This medication management model can be extended to large-area warehouses for total supply chain traceability.

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

Please visit www.deenova.com for additional information on its market leading solutions.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221219005564/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Adaptive announces strategic investment from HSBC and Citi to fuel capital markets technology innovation5.3.2026 14:01:00 CET | Press release

Investment capitalizes on significant technological shifts in capital markets driven by cloud, open-source and AIFunding to scale Adaptive’s development of next-gen cloud-enabled front office solutions, centered around its Aeron® technology Adaptive, a leader in custom trading technology solutions, announces it has secured strategic investment from two prominent global financial institutions, Citi and HSBC. This funding is set to significantly accelerate Adaptive’s growth and product innovation roadmap. The strategic backing from HSBC and Citi underscores the collaboration between Adaptive and two of the world’s largest financial institutions on strategic initiatives to reshape capital markets technology. It will enable Adaptive to capitalize on significant technological disruption and meet the growing demand for client‑owned, differentiated and bespoke trading technology. Centered around Adaptive’s suite of Aeron®products, the funding allows the company to scale its delivery of high-p

CPAC Systems AB Chooses RideController, Inc. Accelerating Intelligent Boat Innovation5.3.2026 14:00:00 CET | Press release

CPAC Systems AB today announces a partnership between its premium marine integration platform Marivue and RideController, Inc. RideController becomes an Integrated Experience Partner within the Marivue ecosystem, advancing integration, automation, and user experience for next generation watersports and recreational boats. The partnership combines Marivue’s digital dashboard, integrated boat architecture, and Horizon cloud platform with RideController’s next generation power distribution and LED control systems. Together, the companies will deliver a fully integrated electrical and lighting experience for watersports and premium recreational vessels. Rather than treating switching and lighting as separate subsystems, the collaboration establishes a cohesive digital and electrical backbone. RideController’s distributed solid state power and advanced LED control technology will integrate into Marivue products, enabling unified control, diagnostics, and mode based automation. “RideControll

LabVantage Solutions Introduces LabVantage CORTEX, Advancing Its LIMS Platform for AI-Driven Laboratory Operations5.3.2026 13:30:00 CET | Press release

—Next-Generation Platform Extends LIMS with Agentic AI and Cloud-Native Automation to Improve Efficiency, Reduce Errors and Gain Deeper Insight from Data —— Learn More from LabVantage Leadership at Pittcon 2026 — LabVantage Solutions, Inc., a global provider of laboratory informatics solutions and services, today announced the launch of LabVantage CORTEX, a next-generation artificial intelligence (AI), analytics, and automation platform. The launch represents a strategic evolution of the company’s laboratory informatics portfolio, integrating advanced AI and smarter automation into the core LabVantage LIMS experience to help laboratories operate with greater accuracy, efficiency, and confidence. LabVantage CORTEX is built to support the growing demand for intelligent, automated laboratory environments across industries, including pharma and biotech, food and beverage, oil and gas, forensics, and more. LabVantage CORTEX provides a customer-centric AI analytics and automation ecosystem t

SOLUM and Simbe Expand European Collaboration to Advance Intelligent Store Operations5.3.2026 08:00:00 CET | Press release

SOLUM (KOSPI: 248070) and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. The collaboration was highlighted at EuroShop, where Simbe’s Store Intelligence™ platform was demonstrated live at the SOLUM booth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304620371/en/ SOLUM and Simbe announced the expansion of their strategic collaboration to further integrate autonomous store intelligence with SOLUM’s Newton Electronic Shelf Label (ESL) infrastructure across Europe. (Image: SOLUM) Simbe recently introduced Tally 4.0, the next generation of their autonomous shelf-scanning robot, reflecting the company’s continued evolution in retail shelf digitization, incorporating extended runtime, enhanced edge computing, and advanced vision capabilities. Designed to deliver deeper shelf coverag

Mosaic Clinical Technologies Announces FDA Breakthrough Device Designation for Cognita’s Generative AI Model for Radiology5.3.2026 08:00:00 CET | Press release

Breakthrough designation means Cognita™ will engage in prioritized interaction with FDA regarding clearance of device designed to help solve the radiology capacity bottleneck Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing generative vision-language models (VLMs) for radiology, has received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for Cognita Chest X-Ray (CXR)™1 across multiple critical indications. Cognita CXR is an industry-first generative vision-language model designed to assist radiologists in the interpretation of chest X-rays and is the first radiology generative AI model, and one of very few radiology AI solutions, to be granted this designation2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260304633206/en/ Cognita™ operates as the AI business unit of Mosaic Clinical Technologies™, a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye